TruSight Oncology 500 ctDNA v2 for Automation (48 samples) plus Illumina Connected Insights Software
Vendor: Illumina
SKU: 20105912
Regular price
30,356.00 NIS
Sale price
Regular price
Unit price
/per
Quote Required
In stock
TSO 500 ctDNA v2 AutomatedKit+ Illumina Connected Insights Software
TruSight Oncology 500 ctDNA v2 is a pan-cancer NGS assay that enables in-house comprehensive genomic profiling (CGP) of circulating tumor DNA (ctDNA) in blood plasma for research.
Documents
- Liquid Biopsy and NGS: Driving translational clinical research to the next level
- Accurate quantification of cfDNA for use in TruSight Oncology 500 ctDNA
- TruSight Oncology 500 ctDNA Gene List
- Data analysis and reporting for the TruSight Oncology 500 portfolio
- Chinese (Simplified)
- TruSight Oncology 500 portfolio
- Brazilian Portuguese
- TruSight Oncology 500 ctDNA v2 provides superior performance and an improved workflow
Support Documentation
- DRAGEN TruSight Oncology 500 ctDNA Analysis Software v1.2 Documentation
- DRAGEN TruSight Oncology 500 ctDNA Analysis Software v2.6 Documentation
- DRAGEN TruSight Oncology 500 ctDNA Local Analysis Software v2.1 Documentation
- TruSight Oncology 500 ctDNA v2 Product Documentation
- DRAGEN TruSight Oncology 500 ctDNA Analysis Software v1.2 on ICA Documentation
- TruSight Oncology 500 ctDNA Checklist Documentation
- DRAGEN TruSight Oncology 500 ctDNA Analysis Software v2.5 Documentation
- DRAGEN TruSight Oncology 500 ctDNA Analysis Software v2.1.1 on ICA Documentation
Specifications
- Area of interest Cancer research, Cell & molecular biology research, Drug discovery & development, Immuno-oncology research
- Assay time 2.5–4 days from purified nucleic acid to variant results
- Automation capability Liquid handling robot(s)
- Cancer type Pan-cancer, Solid tumor
- Content specifications Targeted sequencing of DNA for a total of 1.94 Mb panel size: 523 genes for small variants, 59 genes for CNVs, 23 genes for gene rearrangements, bMSI (> 2300 loci), bTMB (1.94 Mb).
- Hands on time ~1.5 hr for automated workflow ~2.5 hr for manual workflow
- Input quantity 20 ng cfDNA (4 ml of plasma)
- Instruments NextSeq 2000 SystemNovaSeq 6000 SystemNovaSeq 6000Dx in Research ModeNovaSeq X Plus SystemNovaSeq X System
- Key use Genotyping, Targeted analysis, Tumor immunogenicity analysis
- Mechanism of action Hybrid-capture chemistry
- Method Target enrichment, Targeted DNA sequencing
- Multiplexing NextSeq 2000 System: 4 samples on P4 flow cell. NovaSeq 6000 System: 4 samples on S1 flow cell, 8 samples on S2 flow cell, 24 samples on S4 flow cell. NovaSeq X Series: 4 samples on 1.5B flow cell, 24 samples on 10B flow cell, 64 samples on 25B flow cell.
- Nucleic acid type DNA
- Specialized sample types Blood, Circulating tumor DNA
- Species category Human
- Technology Sequencing
- Variant class Blood microsatellite instability (bMSI), Blood tumor mutational burden (bTMB), Copy number variants (CNVs), Gene rearrangements, Insertions-deletions (indels), Multi-nucleotide variants (MNVs), Single nucleotide variants (SNVs)
links and documants
- Datasheet url Click here
- Source url Click here
Couldn't load pickup availability
TruSight Oncology 500 ctDNA v2 for Automation (48 samples) plus Illumina Connected Insights Software
Regular price
30,356.00 NIS
Sale price
Regular price
Unit price
/per
Quick order list
Free shipping on almost everything
Free Shipping
All orders over $500 are delivered to your doorstep at no extra charge.
30-Days Free Returns
Enjoy the freedom of stress-free shopping with our hassle-free and return policy.
Secure Payment
Shop with confidence knowing your payments are secure and your information